Robert Lowery


CEO
BellBrook LabsDr. Robert Lowery received his undergraduate degree in Biochemistry at the University of California, Berkeley and his Ph.D. in Biochemistry at UW-Madison in 1988. Prior to starting BellBrook Labs, Dr. Lowery served for ten years as Vice President of R&D at PanVera Corporation, and previously served as Director of Manufacturing at Promega Corporation, both in Madison, Wisconsin. At PanVera, Dr. Lowery played a key role in bringing to market the first fluorescence based HTS assays for nuclear receptors and protein kinases. At BellBrook, Dr. Lowery has led the development and commercialization of the Transcreener® HTS Assay platform and the iuvo™ Microconduit Array plates. Dr. Lowery’s current efforts are focused on discovery of modulators for the cGAS/STING pathway.
Madison, Wisconsin

Dr. Robert Lowery received his undergraduate degree in Biochemistry at the University of California, Berkeley and his Ph.D. in Biochemistry at UW-Madison in 1988. Prior to starting BellBrook Labs, Dr. Lowery served for ten years as Vice President of R&D at PanVera Corporation, and previously served as Director of Manufacturing at Promega Corporation, both in Madison, Wisconsin. At PanVera, Dr. Lowery played a key role in bringing to market the first fluorescence based HTS assays for nuclear receptors and protein kinases. At BellBrook, Dr. Lowery has led the development and commercialization of the Transcreener® HTS Assay platform and the iuvo™ Microconduit Array plates. Dr. Lowery’s current efforts are focused on discovery of modulators for the cGAS/STING pathway.

Send Email to Robert Lowery